Mrs. Joyelle K Divall Rayan, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7825 Ne 130th Ave, Vancouver, WA 98682 Phone: 360-604-3425 |
Mrs. Renee A Crawford, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2700 Nw 119th St # Stl, Vancouver, WA 98685 Phone: 360-313-1750 |
Dawn Lalonde, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2301 Ne 157th St, Vancouver, WA 98686 Phone: 360-907-6357 |
Kimberly Wilkerson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 246, Vancouver, WA 98684 Phone: 360-696-1070 Fax: 360-737-0200 |
Jenna Lynn Frink, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Grand Blvd, Vancouver, WA 98661 Phone: 360-418-0419 |
Tracy Lee Moser, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6511 Ne 18th St, Vancouver, WA 98661 Phone: 360-759-4917 Fax: 360-759-4921 |
Mr. Francis Timothy Regan, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3212 E Evergreen Blvd, Vancouver, WA 98661 Phone: 360-313-1988 |
Mrs. Gretchen Ann Bell, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 511 Ne Anderson Road, Vancouver, WA 98665 Phone: 360-313-2050 |
Cara Schmitt, PT Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-3750 Fax: 503-413-4379 |
Ms. Brooke Lynne Berard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ne 139th St, Medical Office Building A, Suite #200, Vancouver, WA 98686 Phone: 360-487-1777 |
Rachel Atkinson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11116 Ne 104th St, Vancouver, WA 98662 Phone: 503-893-9474 |
Ms. Jeanie Wagener, MS, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1010 Washington St, Vancouver, WA 98660 Phone: 360-699-6374 |
Jillian E. Sherrodd Wing, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 Ne 139th St, Mob A, Ste 200, Vancouver, WA 98686 Phone: 360-487-1777 Fax: 360-487-1779 |
Rachel Coy Huth Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13501 Ne 28th St, Vancouver, WA 98682 Phone: 306-604-4000 |
Cascade Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1220 Main St Ste 400, Vancouver, WA 98660 Phone: 360-230-8557 Fax: 888-915-0898 |
Julie Anne Hill, MA CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 7101 Ne 137th Ave, Vancouver, WA 98682 Phone: 360-944-2729 |
Krista Whiting, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6511 E 18th St, Vancouver, WA 98661 Phone: 503-567-6326 |
Noralee May Jones, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5616 Ne 64th St, Vancouver, WA 98661 Phone: 435-760-5502 |
Samantha Jean Berkley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2921 Falk Rd # 5683, Vancouver, WA 98661 Phone: 360-313-2600 |
Wendy Kay Kellam, PAC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2811 Ne 139th St, Vancouver, WA 98686 Phone: 360-574-5247 |
News Archive
Researchers in the United States have found that many babies who were delivered vaginally, experience bleeding in and around the brain shortly after birth.
Estimates based on genomic data predict stroke risk with an accuracy similar to, or greater than those based on clinical risk factors. This result implies that persons at high risk might benefit from more rigorous preventive measures.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
"More than seven months overdue, the Global Fund to Fight AIDS, Tuberculosis and Malaria grant will finally be released to key South African AIDS organizations that have been struggling to survive," PlusNews writes, adding, "Some were on the verge of shutting down."
It's one of the most common immune-mediated diseases in the U.S., causing red, patchy and scaly marks on the skin. Yet the 1 to 2 percent of the population who have psoriasis are still left to wonder why.
› Verified 1 days ago